Delivery Order SPE2DB24D3015-SPE2DB25FGBCM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,145.84 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a prescription medication used to manage cholesterol levels. The contract, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $40,099.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This firm fixed-price delivery order, effective September 17, 2025, with completion scheduled for September 18, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $37,535.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This firm fixed-price delivery order, issued on September 9, 2025, with completion targeted for September 10, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,061.18 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement fulfilling federal pharmaceutical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,742.98 for Repatha 140 mg/ml SureClick pharmaceutical supplies. The contract, executed on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,603.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside delivery order, awarded through competitive procurement, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,783.70 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick, a prescription medication used to treat high cholesterol. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,701.45 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,480.40 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,050.46 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Repatha 140 mg/mL SureClick medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGBCMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,276.08 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick, a pharmaceutical product used in cholesterol management. The contract, which was competitively awarded without a set-aside designation, has a firm fixed price structure and was executed on September 25, 2025, with an ultimate completion date of September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp has demonstrated extensive capability in fulfilling diverse medical procurement requirements through its portfolio of competitively awarded contracts with DLA and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/25/25 |